{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-025921","form_type":"8-K","ticker":"PEPG","cik":"0001835597","company_name":"PepGen Inc.","filed_at":"2024-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.863103+00:00","generated_at":"2026-06-06T07:18:03.777825+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PepGen prices $80.1M common stock offering of 7.53M shares at $10.635 per share","bullets":["Gross proceeds ~$80.1M; net proceeds ~$76.4M after underwriting discounts and expenses.","Offering led by RA Capital Management; 11 institutional investors including Adage, Frazier, Janus.","Net proceeds to fund R&D and clinical development of oligonucleotide therapies; cash runway into 2026.","Offering expected to close February 9, 2024; Leerink Partners sole bookrunner."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-025921","json":"https://secwatch.observer/filing/0001193125-24-025921.json","markdown":"https://secwatch.observer/filing/0001193125-24-025921.md","text":"https://secwatch.observer/filing/0001193125-24-025921.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835597/000119312524025921/0001193125-24-025921-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835597/000119312524025921/d695469d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T07:18:03.777825+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1b687359fa8f5772a31eea278673f46e14517edd","claim":"PepGen Inc. entered into Underwriting Agreement with Leerink Partners LLC valued at Underwriting Agreement for 7,530,000 shares of common stock at $10.635 per share, net proceeds appro (effective 2024-02-06).","evidence_excerpt":"On February 6, 2024, PepGen Inc. (the \" Company \") entered into an underwriting agreement (the \" Underwriting Agreement \") with Leerink Partners LLC, as underwriter, pursuant to which the Company agreed to issue and sell an aggregate of 7,530,000 shares (the \" Shares \") of its common stock, par value $0.0001 per share (the \" Common Stock \"), at a price to the public of $10.635 per share.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835597/000119312524025921/0001193125-24-025921-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Leerink Partners LLC"},{"label":"Value","value":"Underwriting Agreement for 7,530,000 shares of common stock at $10.635 per share, net proceeds appro"},{"label":"Effective","value":"2024-02-06"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}